| Symbol | BSPM |
|---|---|
| Name | BIOSTAR PHARMACEUTICALS, INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 712046 China No. 588 Shiji Avenue Xiangyang City |
| Telephone | 86-029-33686638 |
| Fax | — |
| — | |
| Website | http://www.biostarpharmaceuticals.com |
| Incorporation | US |
| Incorporated On | 2007 |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | OTC |
| Auditor | — |
| Audit Status | AUDITED |
| Reporting Status | U.S. Reporting: SEC Reporting |
| CIK | 0001418133 |
| Description | BioStar Pharmaceuticals, Inc., through its wholly-owned subsidiary develops, manufactures, and markets pharmaceutical and medical nutrient products for a variety of diseases and conditions. The Companys most popular product is its Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter (OTC) medicine for Chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. In addition to its hepatitis product, BioStar manufactures two broad-based OTC products, two prescription-based pharmaceuticals and ten nutrients. The Company has adopted international standards and is in the process of applying for three patents. Additional info from OTC: |
Expert Market symbol attribute type Security_Name was changed. Previous value: -. New value: BIOSTAR PHARMS INC.
Read moreOTCQX U.S. Premier symbol attribute type Security_Name was changed. Previous value: CONSUMERS BANCORP INC. New value: BIOSTAR PHARMS INC.
Read more